Not sure if you're posting this as a disagreement with the suggested model, or agreeing. From the link, it looks like it costs ~$10bn per successful drug, at t

Not sure if you're posting this as a disagreement with the suggested model, or agreeing. From the link, it looks like it costs ~$10bn per successful drug, at the top end of that list. Australia paid $750m for 5 years access. Australia has ~1/10th the population of the United States. and ~1/3rd the population of the UK. If just the UK, USA and Australia paid at that same rate (per capita) then they would cover that 10bn average development cost in 5 years. Seems like it's a good suggestion